Expert Opinion on Drug Discovery and online now on Taylor & 
   Francis Online 


   Can 4D bioprinting revolutionize drug development? 
   Izeia Lukin, Saioa Musquiz, Itsasne Erezuma, Taleb H. Al-Tel, Nasim 
   Golafshan, Alireza Dolatshahi-Pirouz & Gorka Orive 
   Pages: 1-4 
   DOI: 10.1080/17460441.2019.1636781 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160829&key=BjYMCKNfBVcBFGC6yb5OFAHIwZ7PRqlYKJIgMOPjQYM%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F17460441.2019.1636781%3Fai%3D1ws9g%26ui%3D843fx%26af%3DT 

   Transforming cancer drug discovery with Big Data and AI 
   Paul Workman, Albert A. Antolin & Bissan Al-Lazikani 
   Pages: 1-7 
   DOI: 10.1080/17460441.2019.1637414 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160829&key=BjYMCKNfBVcBFGC6yb5OFAHIwZ7PRqlYKJIgMOPjQYM%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F17460441.2019.1637414%3Fai%3D1ws9g%26ui%3D843fx%26af%3DT 

   Animal models of synucleinopathies and how they could impact future 
   drug discovery and delivery efforts 
   Kurt A. Jellinger 
   Pages: 1-14 
   DOI: 10.1080/17460441.2019.1638908 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160829&key=BjYMCKNfBVcBFGC6yb5OFAHIwZ7PRqlYKJIgMOPjQYM%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F17460441.2019.1638908%3Fai%3D1ws9g%26ui%3D843fx%26af%3DT 

   Computational re-design of protein structures to improve solubility 
   Susanna Navarro & Salvador Ventura 
   Pages: 1-12 
   DOI: 10.1080/17460441.2019.1637413 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160829&key=BjYMCKNfBVcBFGC6yb5OFAHIwZ7PRqlYKJIgMOPjQYM%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F17460441.2019.1637413%3Fai%3D1ws9g%26ui%3D843fx%26af%3DT 

   Novel screening approaches for human prion diseases drug discovery 
   Fabio Moda, Maria Laura Bolognesi & Giuseppe Legname 
   Pages: 1-11 
   DOI: 10.1080/17460441.2019.1637851 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160829&key=BjYMCKNfBVcBFGC6yb5OFAHIwZ7PRqlYKJIgMOPjQYM%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F17460441.2019.1637851%3Fai%3D1ws9g%26ui%3D843fx%26af%3DT 

   Novel approaches to the discovery of selective human monoamine 
   oxidase-B inhibitors: is there room for improvement? 
   Paolo Guglielmi, Simone Carradori, Alessandra Ammazzalorso & Daniela 
   Secci 
   Pages: 1-41 
   DOI: 10.1080/17460441.2019.1637415 
   https://www.tandfonline.com/action/doSecureKeyLogin?uuid=d8594a82-ce8d-4e6c-8a1f-0da062c12f34&dateTime=201907160829&key=BjYMCKNfBVcBFGC6yb5OFAHIwZ7PRqlYKJIgMOPjQYM%3D&uri=https%3A%2F%2Fwww.tandfonline.com%2Fdoi%2Fabs%2F10.1080%2F17460441.2019.1637415%3Fai%3D1ws9g%26ui%3D843fx%26af%3DT